Correct Answer: A. Serum ceruloplasmin levels
The clinical presentation of hepatitis with progressive neurological degeneration in a child, combined with the visual finding (presumed Kayser-Fleischer ring on slit-lamp examination), is pathognomonic for Wilson's disease (hepatolenticular degeneration). The initial diagnostic step is serum ceruloplasmin measurement, not serum copper, because ceruloplasmin is the primary copper-carrying protein in plasma and its deficiency is the fundamental biochemical defect in Wilson's disease. Ceruloplasmin levels are markedly reduced (<20 mg/dL; normal 20–40 mg/dL) in >95% of symptomatic Wilson's disease patients, making it the most sensitive and specific screening test. Although serum copper may be elevated (free copper), total serum copper can be normal or low because most copper is bound to ceruloplasmin; measuring ceruloplasmin first clarifies the diagnosis. The Kayser-Fleischer ring (copper deposition in Descemet's membrane) is virtually diagnostic when present but requires slit-lamp examination. Ceruloplasmin testing is non-invasive, rapid, and guides further investigation (24-hour urinary copper, slit-lamp examination, genetic testing). Per Harrison and Indian pediatric guidelines, ceruloplasmin is the gold-standard initial biochemical marker for Wilson's disease screening in symptomatic children.
Why the other options are wrong
B. Enzyme assay — Enzyme assays (e.g., for ATP7B gene mutations or ceruloplasmin oxidase activity) are confirmatory or research tools, not initial diagnostic steps. They are expensive, not widely available in Indian labs, and require genetic sequencing. Initial diagnosis relies on biochemical markers (ceruloplasmin), not enzyme activity. This is a trap for students who confuse confirmatory genetic testing with screening. C. Serum copper levels — Although serum copper may be elevated in Wilson's disease, it is NOT the initial test because total serum copper can be normal or low (bound to ceruloplasmin) and is less specific. Free copper is the relevant measure but requires specialized testing. Ceruloplasmin is the standard first-line marker because its deficiency is the pathophysiological hallmark. NBE pairs this option to trap students who focus on copper accumulation rather than the ceruloplasmin defect. D. Karyotyping — Karyotyping is used for chromosomal disorders and genetic syndromes with developmental delay or dysmorphism, not for Wilson's disease. Wilson's disease is an autosomal recessive disorder requiring ATP7B gene sequencing (not karyotyping) for confirmation. This is a distractor for students unfamiliar with the genetic basis of Wilson's disease or who confuse it with chromosomal conditions.
High-Yield Facts
- Ceruloplasmin <20 mg/dL is the most sensitive initial screening test for Wilson's disease; normal is 20–40 mg/dL.
- Kayser-Fleischer rings (copper in Descemet's membrane) are virtually diagnostic but require slit-lamp examination; present in ~95% of neurological Wilson's disease.
- ATP7B gene mutation (autosomal recessive) causes defective copper excretion; diagnosis confirmed by genetic sequencing or 24-hour urinary copper >100 μg/day.
- Hepatic copper >250 μg/g dry weight on liver biopsy is diagnostic but invasive; reserved for atypical presentations.
- Initial presentation in India: hepatitis (50%), neuropsychiatric (40%), or asymptomatic (10%); peak age 8–16 years.
Mnemonics
CERULO-FIRST Ceruloplasmin is the FIRST test in Wilson's disease screening. Enzyme assays and Resting copper are confirmatory. Urinary copper (24-hour) and Liver biopsy follow if ceruloplasmin is low. Ophthalmic exam (Kayser-Fleischer) supports diagnosis. Wilson's Diagnostic Ladder Step 1: Ceruloplasmin (screening). Step 2: Slit-lamp exam + 24-hour urinary copper. Step 3: Liver biopsy or ATP7B sequencing (confirmation). Use this when a child presents with hepatitis + neuro signs.
NBE Trap
NBE pairs serum copper (option D) with Wilson's disease to trap students who focus on copper accumulation rather than the ceruloplasmin deficiency that is the pathophysiological hallmark. Ceruloplasmin, not total copper, is the initial diagnostic marker.
Clinical Pearl
In Indian pediatric practice, Wilson's disease often presents as acute hepatitis in a school-age child with subtle neurological signs (tremor, behavioral change) that parents attribute to school stress. Measuring ceruloplasmin at the first visit prevents misdiagnosis as viral hepatitis and allows early copper chelation therapy (penicillamine or zinc) to prevent irreversible neurological damage.
_Reference: Harrison Ch. 356 (Wilson's Disease); Robbins Ch. 18 (Liver Pathology); OP Ghai Ch. 8 (Metabolic Disorders)_